FIVE AT FIVE: Anthropic files for the record books, London holds its nerve and Computacenter beats forecasts
The much-anticipated IPO of the Claude-maker hogged Monday's headlines
Archive
Column
325 stories · page 1 of 17
FIVE AT FIVE: Musk floats a $3.5 trillion merger, GSK lands an FDA first and Ashtead agrees a £505 million exit
SpaceX and Tesla as one company, a hepatitis B breakthrough and London recovering its nerve
The Australian procurement cycle that keeps slipping its own deadlines
Three state governments have committed to account-based gaming machine systems. All three have moved their dates. Vendors have been building against those...
ASX gains fresh momentum from a surge in trading activity
Australian stock exchange operator ASX has received a welcome lift from stronger trading activity after a difficult period for the company. Higher volumes...